The Claim
Microinjection of the mu-opioid agonist DAMGO into the anterolateral olfactory tubercle of rats reduces hedonic facial reactions to 1% sucrose to 61% of control levels, indicating that this brain region acts as a suppressive hedonic coldspot that dampens pleasure responses.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Injecting DAMGO into a specific brain region in rats reduces their facial expressions of pleasure when tasting sweet solution, showing that this region suppresses pleasure responses.
See the scientific wording
Microinjection of mu-opioid agonist DAMGO into the anterolateral olfactory tubercle of rats reduces hedonic facial reactions to 1% sucrose to 61% of control levels, suggesting this region functions as a suppressive 'hedonic coldspot' that dampens pleasure responses.
When a specific chemical binds to mu-opioid receptors in a part of the brain called the anterolateral olfactory tubercle, it stops neurons there from releasing a signal that normally turns down pleasure. This prevents other brain areas from amplifying the enjoyment of sweet tastes, so the animal shows fewer happy facial reactions to sugar.
What the research says
1 studyScientists injected a chemical into a specific part of rats' brains and found that it made the rats react less happily to sweet tastes—like they didn’t enjoy the sugar as much. This suggests that part of the brain can actually turn down pleasure.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.